左主慢性全闭塞 皮肤穿冠状动脉干预的结果
Dimitrios Strepkos1, Michaella Alexandrou1, Deniz Mutlu1
1Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
概括
对于左主慢性全遮 (LM CTO PCI) 的皮革冠状动脉干预并不常见. 尽管LM CTO PCI具有更高的复杂性和患者的并发症,但它仍然取得了很高的技术成功和可接受的安全结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
背景情况:
- 对于左主 (LM) 慢性全闭 (CTO) 的皮肤穿透冠状动脉干预 (PCI) 很少被研究.
- 由于解剖位置和病变的复杂性,左主CTOPCI存在独特的挑战.
研究的目的:
- 为了比较LM CTO PCI与非LM CTO PCI的临床和程序特征和结果.
- 在一个大型的多中心队列中评估LM CTO PCI的安全性和有效性.
主要方法:
- 在2012年至2024年间在41个国际中心进行的15254个CTO PCI病例的回顾性分析.
- 在LM CTO PCI和非LM CTO PCI组之间比较患者人口统计,病变特征,程序细节和临床结果.
主要成果:
- LM CTO PCI占所有CTO PCI的0.6%,患者患病率较高的并发症和复杂病变.
- 尽管复杂性增加,但LM和非LM CTO PCI之间的技术成功率 (80.5%与87.2%) 和主要不良心血管事件 (MACE) (2.4%与2.0%) 是可比的.
- 之前的冠状动脉旁路移植手术 (CABG) 在LM CTO PCI患者中没有显著影响技术成功或MACE.
结论:
- 左主CTOPCI是一种罕见但可行的手术,与患者显著的并发症和血管学复杂性有关.
- LM CTO PCI可以在高技术成功率和可接受的并发症率下进行,即使是在以前有CABG的患者中.
- 进一步的研究是有必要的,以优化这一具有挑战性的患者子集的结果.
相关概念视频
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...